Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

Genomic predictors of response to doxorubicin versus docetaxel in breast cancer


ABSTRACT: Low topo2a expression and ER-negative status were predictors of response to doxorubicin, while small tumor size and ER-negative status predicted response to docetaxel. Docetaxel was superior to doxorubicin in triple-negative/basal-like tumors, while no significant differences between these drugs were seen in the remaining intrinsic subtypes Keywords: reference x sample reference x sample

ORGANISM(S): Homo sapiens

SUBMITTER: Charles Perou 

PROVIDER: E-GEOD-21997 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

Similar Datasets

2011-03-18 | E-GEOD-22358 | biostudies-arrayexpress
2010-08-31 | E-GEOD-20624 | biostudies-arrayexpress
2009-04-01 | E-GEOD-10885 | biostudies-arrayexpress
2010-10-25 | E-GEOD-15393 | biostudies-arrayexpress
2009-03-31 | E-GEOD-3521 | biostudies-arrayexpress
2010-06-25 | E-GEOD-10884 | biostudies-arrayexpress
2010-06-24 | E-GEOD-10886 | biostudies-arrayexpress
2011-12-31 | E-GEOD-31589 | biostudies-arrayexpress
2010-01-06 | E-GEOD-16113 | biostudies-arrayexpress
2009-01-18 | E-GEOD-11429 | biostudies-arrayexpress